MF Update : Equity inflows rises despite volatility
MF Update : Equity inflows rises despite volatility

MF Update : Equity inflows rises despite volatility

Nikhil Desai Article rating: 5.0

During the month of May 2018, the mutual fund industry has witnessed net inflows of Rs. 16,710 crore in equity funds which include pure equity funds, balanced funds, ELSS and equity ETFs

Tata Motors plans USD 250-500 million fund raise
Tata Motors plans USD 250-500 million fund raise

Tata Motors plans USD 250-500 million fund raise

Nikita Singh Article rating: 5.0

Automobile giant Tata Motors shot up by over 2 per cent in Friday’s intraday trade session on the back of the company’s fund raise plans. The company announced on Thursday evening that it has proposed to raise funds worth USD 250-500 million via external commercial borrowing.

PSU banks hold the markets, Index witnesses breakout
PSU banks hold the markets, Index witnesses breakout

PSU banks hold the markets, Index witnesses breakout

Bhagyashree Vivarekar Article rating: 2.0

PSU Bank index posted a Doji and bounced back from 50 per cent retracement of the prior upward rally from 2,645 to 3,055. Thereafter, it has given three consecutive daily upbeats till date. Volumes are rising and 14-period RSI is nearing 60 which suggests momentum.

Aurobindo Pharma receives USFDA nod for Omeprazole tablets production
Aurobindo Pharma receives USFDA nod for Omeprazole tablets production

Aurobindo Pharma receives USFDA nod for Omeprazole tablets production

Nikita Singh Article rating: 5.0

Pharma major Aurobindo Pharma surged by over 3 per cent in Friday’s intraday trade as the company received the final nod from the US health regulator US Food and Drugs Association to manufacture Omeprazole delayed release tablets OTC.

Nifty Pharma outperforms, frontliners gain on news
Nifty Pharma outperforms, frontliners gain on news

Nifty Pharma outperforms, frontliners gain on news

Bhagyashree Vivarekar Article rating: 1.5

When the entire market is in doldrums with weakness prevailing in the benchmark indices, Pharma sector has escalated by 2.9 per cent. We hold 8555-8600 followed by 8650 as the resistances. In case its a pullback we hold 8330-8215 as the supports.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Shital Jibhe Article rating: 3.5

The markets on June 8, 2018 opened gap down. BSE Sensex is trading at 35,268.78, down by 194.30 points and the Nifty is trading at 10,709.90, down by 58.45 points.

Omax Autos hits upper circuit on capacity expansion
Omax Autos hits upper circuit on capacity expansion

Omax Autos hits upper circuit on capacity expansion

Apurva Joshi Article rating: 5.0

The Board of Directors of Omax Autos approved the proposal for diversification and expansion of existing capacity for manufacturing products and equipment supplied to the Indian Railways. The meeting was held on June 7, 2018.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 3.3

Overall volumes in futures & options currently stand at 1.79 crore contracts with a turnover of Rs. 18,18,786.62 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 1.79 crore contracts with a turnover of Rs. 18,18,786.62 crore.

RSS
First33103311331233133315331733183319Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR